Is Ironwood Pharmaceuticals, Inc. overvalued?

Ironwood Pharmaceuticals, Inc. (IRWD) looks undervalued — trading about 153% below its fair value.

Undervalued

Price

$4.12

Fair value

$10.43

Current P/E

6.8

Normal P/E

17.1

Market cap

$678.2M

Dividend yield

0.0%

Return on equity

-57.4%

Sector

Healthcare

Fair value compares IRWD's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.

Related stocks